CDH1 and lip and oral cavity carcinoma: Despite the observed elongated cell morphology, which may be associated with the localisation pattern of E-Cadherin in response to mifepristone, the findings underscore the efficacy of mifepristone in inhibiting both the migration and proliferation of oral cancer cells (Figure 8).